SICEM 2026

Chairpersons : Moo-Il Kang (The Catholic University of Korea, Korea), Sangmo Hong (Hanyang University, Korea)

	12:00-12:15	Importance of early, intensive glycemic control in the management of type 2 diabetes Stephan Jacob (Cardio Metabolic Institute and University of Tübingen, Germany)
	12:15-12:30	Novel enhanced SGLT2 inhibitor_enavogliflozin and its impact on adipokine modulation Young Sang Lyu (Chosun University, Korea)

Chairpersons : Seak Ki Yun (Cheon An Endo Medical Clinic, Korea), Keeho Song (Konkuk University, Korea)

	12:00-12:15	Key trial results in semaglutide: Clinical evidence transforming diabetes and comorbidity management Boyeon Kim (Soon Chun Hyang University, Korea)
	12:15-12:30	The standard of Korean diabetes care: Why K-evidence matters Hae Kyung Kim (Yonsei University, Korea)

Chairpersons : Dongsun Kim (Hanyang University, Korea), In Joo Kim (Kim Yong Ki Internal Medicine Clinic, Korea)

	12:00-12:15	Revisiting the role of DPP-4 inhibitors: An evidence-based perspective Eun Young Lee (The Catholic University of Korea, Korea)
	12:15-12:30	Initiating DPP-4i/SGLT-2i combination: Who, when, and how? Yong-ho Lee (Yonsei University, Korea)

Chairpersons: Kyoil Suh (Soon Chun Hyang University, Korea), Kyoung-Ah Kim (Dongguk University, Korea)

	12:00-12:15	The efficacy of early combination therapy with DPP-4 inhibitors and TZDs Eun Roh (Seoul National University, Korea)
	12:15-12:30	Exploring clinical data for hypertensive patients with diabetic kidney disease: Irbesartan+Amlodipine Jong Han Choi (Konkuk University, Korea)

Chairpersons : Yoon-Sok (Martin) Chung (Ajou University, Korea), Suk Kyeong Kim (Konkuk University, Korea)

	12:00-12:15	Is better possible?: Simplify and amplify diabetes management with FRC intensification Daham Kim (Yonsei University, Korea)
	12:15-12:30	Early intervention in CKM care: The role of finerenone Nam Hoon Kim (Korea University, Korea)

Chairpersons : Yeon Ah Sung (Ewha Womans University, Korea), Sung-Hoon Kim (Mizmedi Hospital, Korea)

	12:00-12:15	Redefining early CKM care in treatment-naïve T2DM: Insights from EMPA-FIT Joonyub Lee (The Catholic University of Korea, Korea)
	12:15-12:30	Optimal clinical approach to combination use of SGLT2i and DPP-4i in the management of T2DM Kyung-Soo Kim (CHA University, Korea)

Scientific program